Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect.

Kumaraguru J, Flanagan SE, Greeley SA, Nuboer R, Støy J, Philipson LH, Hattersley AT, Rubio-Cabezas O.

Diabetes Care. 2009 Aug;32(8):1428-30. doi: 10.2337/dc09-0280. Epub 2009 May 12.

2.

Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.

Bremer AA, Ranadive S, Lustig RH.

Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24.

PMID:
18221420
3.

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.

Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, Ashcroft FM, Hattersley AT.

Diabetologia. 2016 Jun;59(6):1162-6. doi: 10.1007/s00125-016-3921-8. Epub 2016 Mar 31.

4.

Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.

Ješić MM, Ješić MD, Maglajlić S, Sajić S, Necić S.

Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5.

PMID:
21056492
6.

Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.

Wambach JA, Marshall BA, Koster JC, White NH, Nichols CG.

Pediatr Diabetes. 2010 Jun;11(4):286-8. doi: 10.1111/j.1399-5448.2009.00557.x. Epub 2009 Jul 29.

7.

Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.

Al-Mahdi M, Al Mutair A, Al Balwi M, Hussain K.

Ann Saudi Med. 2010 Mar-Apr;30(2):162-4. doi: 10.4103/0256-4947.60526. Erratum in: Ann Saudi Med. 2010 May-Jun;30(3):242.

8.
9.

Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.

Siklar Z, Ellard S, Okulu E, Berberoğlu M, Young E, Savaş Erdeve S, Mungan IA, Hacihamdioğlu B, Erdeve O, Arsan S, Oçal G.

J Pediatr Endocrinol Metab. 2011;24(11-12):1077-80.

PMID:
22308870
10.
11.

Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.

Della Manna T, Battistim C, Radonsky V, Savoldelli RD, Damiani D, Kok F, Pearson ER, Ellard S, Hattersley AT, Reis AF.

Arq Bras Endocrinol Metabol. 2008 Nov;52(8):1350-5.

12.

First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.

Ioacara S, Flanagan S, Fröhlich-Reiterer E, Goland R, Fica S.

J Diabetes Investig. 2017 Sep;8(5):716-719. doi: 10.1111/jdi.12620. Epub 2017 Feb 16.

13.

Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.

Lau E, Correia C, Freitas P, Nogueira C, Costa M, Saavedra A, Costa C, Carvalho D, Fontoura M.

Arch Endocrinol Metab. 2015 Dec;59(6):559-61. doi: 10.1590/2359-3997000000076. Epub 2015 Aug 28.

14.
15.

Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.

Myngheer N, Allegaert K, Hattersley A, McDonald T, Kramer H, Ashcroft FM, Verhaeghe J, Mathieu C, Casteels K.

Diabetes Care. 2014 Dec;37(12):3333-5. doi: 10.2337/dc14-1247. Epub 2014 Sep 17.

16.

No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.

Iafusco D, Bizzarri C, Cadario F, Pesavento R, Tonini G, Tumini S, Cauvin V, Colombo C, Bonfanti R, Barbetti F.

Diabetologia. 2011 Oct;54(10):2736-8. doi: 10.1007/s00125-011-2273-7. Epub 2011 Aug 7. No abstract available.

PMID:
21822789
17.
18.

Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene.

Doneray H, Houghton J, Tekgunduz KS, Balkir F, Caner I.

J Pediatr Endocrinol Metab. 2014 Mar;27(3-4):367-71. doi: 10.1515/jpem-2013-0068.

PMID:
24150202
19.

KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.

Yang W, Wei H, Sang Y.

J Pediatr Endocrinol Metab. 2013;26(5-6):591-4. doi: 10.1515/jpem-2012-0133.

PMID:
23640936
20.

Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.

Philla KQ, Bauer AJ, Vogt KS, Greeley SA.

Diabetes Care. 2013 Dec;36(12):e201. doi: 10.2337/dc13-1690. Review. No abstract available. Erratum in: Diabetes Care. 2014 Feb;37(2):588.

Supplemental Content

Support Center